Dabco → HCID 11508430, compound
Reaction equation
[C:1]([O:5][CH2:6][C:7]1[CH:12]=[CH:11][C:10]([Cl:13])=[C:9]([Cl:14])[CH:8]=1)(=[O:4])[CH:2]=[CH2:3].[S:15]1[CH:19]=[CH:18][N:17]=[C:16]1[CH:20]=[O:21].C1N2CCN(CC2)C1>>[OH:21][CH:20]([C:16]1[S:15][CH:19]=[CH:18][N:17]=1)[C:2](=[CH2:3])[C:1]([O:5][CH2:6][C:7]1[CH:12]=[CH:11][C:10]([Cl:13])=[C:9]([Cl:14])[CH:8]=1)=[O:4]Participants
4
Procedure
A mixture of 59 mg (0.26 mmol) of 3,4-dichlorophenylmethyl acrylate, 27 mg (0.24 mmol) of 2-thiazolecarboxaldehyde, and 31 mg (0.28 mmol) of DABCO was thoroughly shaken on a Vortex mixer, and then stored at 0° C. overnight. The product was purified by prep HPLC to give 34 mg (0.10 mmol; 42% yield) of the desired Baylis-Hillman adduct, 3,4-dichlorophenylmethyl β-hydroxy-α-methylene-2-thiazolepropanoate. 1H NMR (CDCl3): δ 5.12 (2H), 5.76 (1H), 6.07 (1H), 6.49 (1H), 7.12 (d of d, 1H), 7.71 ppm (d, 1H) MS m/z: 344.0 (M+H).
Workup
- customThe product was purified by prep HPLC
Sources & evidence
- ORD record
- ord-9ea37c5fa74b4a2f9f4f39086ae86385
- Source dataset
- uspto-grants-2009_06
- Patent number
- US07541472B2
Reaction notes
Loading…